文献速递临床试验与 GCP真实世界研究与卫生经济

辅助步行改善老年内科住院患者健康结局(AMBULATE):一项随机对照试验的研究方案

Assisted ambulation to improve health outcomes for older medical inpatients (AMBULATE): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2023-07-24

AMBULATE研究是一项多中心、单盲、平行对照、个体水平随机试验,纳入美国两个地区五家医院内科病房65岁以上轻度功能缺陷患者,干预组由移动技术员根据约翰霍普金斯移动目标计算器指导每日最多三次步行,主要结局为出院时简易体能状况量表评分。

要点

  • 老年住院患者卧床时间可高达95%,观察性研究提示步行干预可减少不良事件并改善功能状态。
  • 移动技术员辅助步行能否改善结局及成本效益尚无数据,本研究旨在评估。
  • 主要结局为出院时简易体能状况量表评分,次要结局包括出院去向、住院时长、医院获得性并发症和出院后功能状态。

核心结论

  • 研究旨在确定移动技术员辅助步行能否改善老年内科住院患者的移动状态并减少不良事件,同时分析最受益患者及雇佣移动技术员的成本效益。

研究设计与样本

  • 多中心、单盲、平行对照、个体水平随机试验,纳入美国两个地区五家医院内科病房65岁以上轻度功能缺陷患者,采用区组随机方案。

主要发现

  • 原文未报告研究结果。

关键数值与推荐

  • 干预组由移动技术员指导步行,每日最多三次,依据约翰霍普金斯移动目标计算器,干预至出院或住院延长时10天后终止。
  • 主要结局为出院时简易体能状况量表评分。
  • 次要结局包括出院去向、住院时长、医院获得性并发症(跌倒、静脉血栓栓塞、压力性损伤和医院获得性肺炎)及出院后功能状态。
  • 试验注册于美国国家医学图书馆clinicaltrials.gov(# NCT05725928),注册日期2023年2月13日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hospitalized older adults spend as much as 95% of their time in bed, which can result in adverse events and delay recovery while increasing costs. Observational studies have shown that general mobility interventions (e.g., ambulation) can mitigate adverse events and improve patients' functional status. Mobility technicians (MTs) may address the need for patients to engage in mobility interventions without overburdening nurses. There is no data, however, on the effect of MT-assisted ambulation on adverse events or functional status, or on the cost tradeoffs if a MT were employed. The AMBULATE study aims to determine whether MT-assisted ambulation improves mobility status and decreases adverse events for older medical inpatients. It will also include analyses to identify the patients that benefit most from MT-assisted mobility and assess the cost-effectiveness of employing a MT. METHODS: The AMBULATE study is a multicenter, single-blind, parallel control design, individual-level randomized trial. It will include patients admitted to a medical service in five hospitals in two regions of the USA. Patients over age 65 with mild functional deficits will be randomized using a block randomization scheme. Those in the intervention group will ambulate with the MT up to three times daily, guided by the Johns Hopkins Mobility Goal Calculator. The intervention will conclude at hospital discharge, or after 10 days if the hospitalization is prolonged. The primary outcome is the Short Physical Performance Battery score at discharge. Secondary outcomes are discharge disposition, length of stay, hospital-acquired complications (falls, venous thromboembolism, pressure ulcers, and hospital-acquired pneumonia), and post-hospital functional status. DISCUSSION: While functional decline in the hospital is multifactorial, ambulation is a modifiable factor for many patients. The AMBULATE study will be the largest randomized controlled trial to test the clinical effects of dedicating a single care team member to facilitating mobility for older hospitalized patients. It will also provide a useful estimation of cost implications to help hospital administrators assess the feasibility and utility of employing MTs. TRIAL REGISTRATION: Registered in the United States National Library of Medicine clinicaltrials.gov (# NCT05725928). February 13, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Johnson JK, Hamilton AC, Hu B, et al. Assisted ambulation to improve health outcomes for older medical inpatients (AMBULATE): study protocol for a randomized controlled trial. Trials. 2023. PMID: 37488588. doi:10.1186/s13063-023-07501-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。